Steward Partners Investment Advisory’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Steward Partners Investment Advisory's ONC Position: Q2 2026 in Review
Steward Partners Investment Advisory reduced its BeOne Medicines Ltd (ONC) stake by 2.6% in Q2 2026, selling an estimated $5.6K and leaving 706 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #2226.
Steward Partners Investment Advisory first reported a position in ONC in Q2 2018 and has held it in 20 quarters since. The position peaked at $246K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- Steward Partners Investment Advisory held 706 shares of BeOne Medicines Ltd worth $201K as of Q2 2026.
- Steward Partners Investment Advisory sold 19 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.6K.
- BeOne Medicines Ltd made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2226 holding.
- Steward Partners Investment Advisory first reported a position in BeOne Medicines Ltd in Q2 2018 and has held it in 20 quarters since.
- Steward Partners Investment Advisory's BeOne Medicines Ltd position peaked at $246K in Q3 2025.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.